CD44 and gastric cancer: High CD44 expression has been observed in gastric cancer stem cells, and SPP1-expressing TAMs correlated with a worse clinical outcome in gastric cancer, suggesting the SPP1/CD44 axis may be associated with stemness properties and resistance to anticancer therapies.